We are live on ! Find out more
HGI

Hansberger Growth Investors Portfolio holdings

AUM $88.2M
1-Year Est. Return 24.07%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+24.07%
3 Year Est. Return
+36.41%
5 Year Est. Return
+96.37%
10 Year Est. Return
–
AUM
$73.4M
AUM Growth
-$12.3M
Cap. Flow
-$17M
Cap. Flow %
-23.14%
Top 10 Hldgs %
82.76%
Holding
18
New
–
Increased
8
Reduced
9
Closed
1
Avg Time Held
8.3 quarters
Top 10 Avg Time Held
7.2 quarters
Top 20 Avg Time Held
6.1 quarters

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$297K
2
CUK
Carnival PLC
CUK
+$255K
3
SCCO icon
Southern Copper
SCCO
+$150K
4
DEO icon
Diageo
DEO
+$138K
5
CS
Credit Suisse Group
CS
+$111K

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$2.78M
2
BABA icon
Alibaba
BABA
+$2.58M
3
ASML icon
ASML
ASML
+$2.55M
4
MFC icon
Manulife Financial
MFC
+$2.34M
5
NXPI icon
NXP Semiconductors
NXPI
+$2M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Technology 27.17%
3 Consumer Discretionary 16.21%
4 Industrials 10.07%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ASML icon
1
ASML
ASML
$680B
$9.19M 12.53%
70,524
-19,260
-21% -$2.55M
2014 Q4
10 quarters
MFC icon
2
Manulife Financial
MFC
$69.7B
$8.67M 11.82%
462,116
-132,891
-22% -$2.34M
2014 Q4
10 quarters
BABA icon
3
Alibaba
BABA
$263B
$8.22M 11.21%
58,356
-20,875
-26% -$2.58M
2015 Q2
8 quarters
NXPI icon
4
NXP Semiconductors
NXPI
$58.3B
$7.68M 10.47%
70,193
-18,657
-21% -$2M
2014 Q4
10 quarters
CP icon
5
Canadian Pacific Kansas City
CP
$74.2B
$7.39M 10.07%
229,665
-62,630
-21% -$1.94M
2015 Q1
9 quarters
HDB icon
6
HDFC Bank
HDB
$113B
$6.62M 9.02%
304,356
-88,636
-23% -$1.85M
2014 Q4
10 quarters
CUK
7
DELISTED
Carnival PLC
CUK
$3.67M 5.01%
55,547
+4,105
+8% +$255K
2014 Q4
10 quarters
CCJ icon
8
Cameco
CCJ
$37.9B
$3.62M 4.93%
397,351
-127,295
-24% -$1.27M
2014 Q4
10 quarters
ASX icon
9
ASE Group
ASX
$118B
$3.06M 4.18%
485,559
-123,136
-20% -$771K
2016 Q3
3 quarters
PUK icon
10
Prudential
PUK
$29.4B
$2.6M 3.54%
58,209
-3,093
-5% -$134K
2014 Q4
10 quarters
CS
11
DELISTED
Credit Suisse Group
CS
$2.28M 3.1%
156,061
+7,719
+5% +$111K
2014 Q4
10 quarters
SCCO icon
12
Southern Copper
SCCO
$168B
$1.99M 2.71%
62,680
+4,669
+8% +$150K
2014 Q4
10 quarters
SHPG
13
DELISTED
Shire pic
SHPG
$1.97M 2.69%
11,945
+586
+5% +$102K
2016 Q1
5 quarters
DEO icon
14
Diageo
DEO
$48.4B
$1.74M 2.38%
14,543
+1,159
+9% +$138K
2017 Q1
1 quarter
NVO
15
Novo Nordisk
NVO
$169B
$1.72M 2.34%
80,100
+14,706
+22% +$297K
2014 Q4
10 quarters
GRFS
16
Grifois
GRFS
$5.04B
$1.49M 2.03%
70,639
+3,514
+5% +$73.6K
2014 Q4
10 quarters
RDS.B
17
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.46M 1.98%
26,758
+1,997
+8% +$111K
2016 Q1
5 quarters
RDY icon
18
Dr. Reddy's Laboratories
RDY
$10.2B
– –
-346,610
Closed -$2.78M –

Similar funds

QCMC
Quantum Capital Management (California) San Francisco, California $89.7M AUM 27.84% 1-Year Est. Return
WMA
White Mountains Advisors Guilford, Connecticut $84.7M AUM 12.82% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
ILM
Indigo Latam Management Phoenix, Arizona $100M AUM 27.97% 1-Year Est. Return
VC
Voit & Company Brookfield, Wisconsin $103M AUM 30.18% 1-Year Est. Return
MUS
Mitsubishi UFJ Securities Tokyo, Japan $69.4M AUM 17.25% 1-Year Est. Return
RICHC
Renaissance Investment Consultants Holding Company Wayne, Pennsylvania $107M AUM 18.13% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Hansberger Growth Investors's Q2 2017 Portfolio in Review

As of Q2 2017, Hansberger Growth Investors held 18 positions worth $73.4M, down 14% from $85.6M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Hansberger Growth Investors withdrew a net $17M in Q2 2017, closing 1 position and reducing 9 holdings. Its most notable exit was Dr. Reddy's Laboratories, an estimated $2.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hansberger Growth Investors added an estimated $297K to Novo Nordisk.

  • Hansberger Growth Investors added most to Novo Nordisk in Q2 2017, an estimated $297K increase.
  • Hansberger Growth Investors's biggest Q2 2017 reduction was Alibaba, cutting an estimated $2.58M.
  • Hansberger Growth Investors fully exited Dr. Reddy's Laboratories in Q2 2017, selling an estimated $2.78M.
  • Hansberger Growth Investors's ten largest holdings make up 83% of its $73.4M portfolio in Q2 2017.
  • Hansberger Growth Investors opened 0 new positions and closed 1 in Q2 2017.
  • Hansberger Growth Investors's portfolio value fell 14% quarter-over-quarter to $73.4M.

Based on Hansberger Growth Investors's 13F filing for Q2 2017, filed 14 Aug 2017.